Ibex Wealth Advisors Purchases New Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Ibex Wealth Advisors acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 250,041 shares of the real estate investment trust's stock, valued at approximately $5,056,000.

Other hedge funds have also recently bought and sold shares of the company. Douglas Lane & Associates LLC raised its position in shares of Healthpeak Properties by 8.5% during the 1st quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after purchasing an additional 218,395 shares during the last quarter. Two Sigma Advisers LP purchased a new stake in shares of Healthpeak Properties in the fourth quarter valued at $5,691,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Healthpeak Properties during the fourth quarter valued at $30,153,000. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Healthpeak Properties by 25.7% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust's stock worth $2,213,000 after purchasing an additional 22,300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in Healthpeak Properties by 16.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock worth $2,217,000 after purchasing an additional 15,753 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on DOC shares. Wedbush decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Evercore ISI dropped their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Finally, Argus reissued a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $23.27.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 11,337 shares of the company's stock in a transaction dated Monday, April 28th. The shares were bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the transaction, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. This trade represents a 5.95% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John T. Thomas acquired 4,200 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the transaction, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 29,764 shares of company stock valued at $521,909 in the last three months. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC traded down $0.11 on Wednesday, reaching $17.50. 4,765,559 shares of the company's stock were exchanged, compared to its average volume of 5,165,129. The firm has a market capitalization of $12.15 billion, a price-to-earnings ratio of 49.99, a PEG ratio of 2.17 and a beta of 1.04. The business's 50-day moving average is $17.75 and its two-hundred day moving average is $19.50. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a fifty-two week low of $16.64 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company's revenue was up 15.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.45 earnings per share. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were paid a $0.1017 dividend. This represents a yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's dividend payout ratio is 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.